Freyer, G., Kalinka-Warzocha, E., Syrigos, K., Marinca, M., Tonini, G., Ng, S. L., . . . Szabo, Z. (2015). Attitudes of physicians toward assessing risk and using granulocyte colony-stimulating factor as primary prophylaxis in patients receiving chemotherapy associated with an intermediate risk of febrile neutropenia.
Citación estilo ChicagoFreyer, Gilles, et al. Attitudes of Physicians Toward Assessing Risk and Using Granulocyte Colony-stimulating Factor As Primary Prophylaxis in Patients Receiving Chemotherapy Associated With an Intermediate Risk of Febrile Neutropenia. 2015.
Cita MLAFreyer, Gilles, et al. Attitudes of Physicians Toward Assessing Risk and Using Granulocyte Colony-stimulating Factor As Primary Prophylaxis in Patients Receiving Chemotherapy Associated With an Intermediate Risk of Febrile Neutropenia. 2015.